Related Experiment Video
Updated: Nov 12, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective
Vishal Kumar1, Sanjeev Dhawan1, Pankaj Sanjay Girase1
1Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal (Westville Campus), Durban-4000, South Africa.
Chalcones exhibit diverse anticancer activities by inhibiting multiple molecular targets. Structural modifications enhance their potency, offering potential for developing novel cancer chemotherapy drugs.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Chemistry
Background:
- Chalcones are versatile compounds with significant biological activities.
- They have demonstrated potent anticancer properties through various mechanisms.
- Research interest in chalcones for health benefits is continuously growing.
Purpose of the Study:
- To review the impact of structural variations on the anticancer efficacy of chalcone hybrids.
- To elucidate the mechanisms of action and molecular targets of these compounds.
- To assess their potential in advancing cancer chemotherapy.
Main Methods:
- Literature review of studies published in 2018-2019.
- Analysis of structure-activity relationships (SAR) of chalcone hybrids.
- Compilation of data on molecular targets and biological activities.
Main Results:
- Chalcone hybrids show significant anticancer activity by targeting key molecules like ABCG2, AR, HDAC, and VEGF.
- Structural modifications significantly influence anticancer potency and selectivity.
- Understanding mechanisms of action aids in designing more effective anticancer agents.
Conclusions:
- Chalcone hybrids represent a promising scaffold for developing novel anticancer therapeutics.
- Further research into their mechanisms and SAR can optimize drug design.
- These compounds hold potential for future cancer chemotherapy strategies.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Prochirality
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

